Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 2/2012

01-04-2012 | Translational Strategies for Diabetes Prevention (D Marrero, Section Editor)

Can Lifestyle Interventions Do More Than Reduce Diabetes Risk? Treating Depression in Adults With Type 2 Diabetes With Exercise and Cognitive Behavioral Therapy

Authors: Mary de Groot, Todd Doyle, Michael Kushnick, Jay Shubrook, Jennifer Merrill, Erin Rabideau, Frank Schwartz

Published in: Current Diabetes Reports | Issue 2/2012

Login to get access

Abstract

The epidemic of metabolic syndrome, prediabetes, and type 2 diabetes is global in scope and comprehensive in its impact on individuals, health care systems, and societies. One in four patients with diabetes will experience depression in their lifetime. Comorbid depression is associated with poorer outcomes, greater functional disability, and early mortality. Prior studies have demonstrated beneficial effects of exercise as an efficacious form of treatment for depression in the general population. Few studies have evaluated this strategy in patients with prediabetes or type 2 diabetes. Program ACTIVE (Appalachians Coming Together to Increase Vital Exercise) was designed to treat depression among adults with type 2 diabetes by pairing aerobic activity with individual cognitive behavioral therapy. This combination treatment approach has been shown to be feasible to implement in a rural environment and promising in terms of depression, diabetes, and cardiovascular outcomes. Data from this study suggest that exercise can be used to achieve multiple benefits for adults with type 2 diabetes. Future work to compare this approach to singular treatment strategies for adults at risk for type 2 diabetes is needed.
Literature
1.
Schwartz F, Ruhil A, Denham S, Shubrook J, Simpson C, Boyd S. High self-reported prevalence of diabetes mellitus, heart disease and stroke in eleven counties in rural Appalachian Ohio. J Rural Health, Spring. 2009;2009:225–9.
2.
American Diabetes Association. Diabetes 2001 vital statistics. Alexandria: American Diabetes Association; 2001.
3.
Robbins JM, Vaccarino V, Zhang H, Kasl SV. Socioeconomic status and type 2 diabetes in African American and Non-Hispanic White women and men: evidence from the Third National Health and Nutrition Examination Survey. Am J Public Health. 2001;91(1):76–83.PubMedCrossRef
4.
Weng C, Coppini DV, Sonksen PH. Geographic and social factors are related to increased morbidity and mortality rates in diabetic patients. Diabet Med. 2000;17(8):612–7.PubMedCrossRef
5.
Robinson N, Lloyd CE, Stevens LK. Social deprivation and mortality in adults with diabetes mellitus. Diabet Med. 1998;15:205–12.PubMedCrossRef
6.
Tang M, Chen Y, Krewski D. Gender-related differences in the association between socioeconomic status and self-reported diabetes. Int J Epidemiol. 2003;32:381–5.PubMedCrossRef
7.
Anderson RJ, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069–78.PubMedCrossRef
8.
Lustman PJ, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23(7):934–42.PubMedCrossRef
9.
de Groot M, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63:619–30.PubMed
10.
Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM. Depression and coronary heart disease in women with diabetes. 2002
11.
Egede LE. Diabetes, major depression and functional disability among U.S. adults. Diabetes Care. 2004;27(2):421–8.PubMedCrossRef
12.
Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25(3):464–70.PubMedCrossRef
13.
Katon WJ, Russo JE, Heckbert SR, Lin EHB, Ciechanowski P, Ludman E, Young B, von Korff M. The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatr. 2009. doi:10.​1002/​gps.​2363.
14.
Egede L, Ellis C, Grubaugh A. The effect of depression on self-care behaviors and quality of care in a national sample of adults with diabetes. Gen Hosp Psychiatr. 2009;31:422–7.CrossRef
15.
Jacobson AM, de Groot M, Samson JA. The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus. Qual Life Res. 1997;6(1):11–20.PubMedCrossRef
16.
Egede L, Osborn C. Role of motivation in the relationship between depression, self-care and glycemic control in adults with type 2 diabetes. Diabetes Educat. 2010;36(2):276–83.CrossRef
17.
Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28(11):2668–72.PubMedCrossRef
18.
Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005;161(7):652–60.PubMedCrossRef
19.
Lin E, Heckbert S, Rutter C, Katon W, Ciechanowski P, Ludman E, Oliver M, Young B, McCulloch D, von Korff M. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med. 2009;7:414–21.PubMedCrossRef
20.
Koopsman B, Pouwer F, de Bie RA, van Rooji E, Leusink G, Pop V. Depressive symptoms are associated with physical inactivity in patients with type 2 diabetes. The DIAZOB Primary Care Diabetes Study. Fam Pract. 2009;26:171–3.CrossRef
21.
Lysy Z, Da Costa D, Dasgupta K. The association of physical activity and depression in type 2 diabetes. Diabet Med. 2008;25:1133–41.PubMedCrossRef
22.
•• Katon WJ, Russo J, Heckbert S, Lin E, Ciechanowski P, Ludman E, Young B, Von Korff M. The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry. 2010;25:466–75. This study reports data on depressive symptoms and health behaviors over a 5-year period after treatment for depression in the IMPACT study. The authors found that depression adversely affects exercise, even when depressive symptoms improve over time. CrossRef
23.
The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. PMCID: PMC1370926.CrossRef
24.
Blumenthal JA, Babyak MA, Moore KA, Craighead E, Herman S, Khatri P, Waugh R, Napolitano MA, Forman LM, Appelbaum M, Doraiswamy M, Krishnan R. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159:2349–56.PubMedCrossRef
25.
Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, Moore K, Craighead E, Baldewicz TT, Krishnan R. Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000;62:633–8.PubMed
26.
Craft LL, Landers DM. The effect of exercise on clinical depression and depression resulting from mental illness: a meta-analysis. J Sport Exerc Psychol. 1998;20:339–57.
27.
Blumenthal J, Babyak M, Doriswamy M, Watkins L, Hoffman BM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69:587–96.PubMedCrossRef
28.
Levinger I, Selig S, Goodman C, Jerums G, Stewart A, Hare D. Resistance training improves depressive symptoms in individuals at high risk for type 2 diabetes. J Strength Condit Res. 2011;25:2328–33.CrossRef
29.
•• Piette J, Richardson C, Himle J, Duffy S, Torres T Vogel M, Barber K, Valenstein M. A randomized trial of telephonic counseling plus walking for depressed diabetic patients. Medical Care. 2011;49:641–8. This study reports findings from the 12-month follow-up time point for a randomized controlled trial of treating self-reported depressive symptoms with 12 sessions of telephone counseling and walking. The authors report improvements in depressive symptoms, number of steps walked, systolic blood pressure, and health-related quality of life at 12 months. No differences in HbA 1c between the intervention and control groups were observed. PubMedCrossRef
30.
Williams JBW, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, Howes MJ, Kane J, Pope Jr HG, Rounsaville B, Wittchen H-U. The structured clinical interview for DSM-III-R (SCID)–II. Multisite test-retest reliability. Arch Gen Psychiatry. 1992;49:630–6.PubMedCrossRef
31.
Beck AT, Steer RA, Brown GK. BDI-II beck depression inventory manual. 2nd ed. San Antonio: The Psychological Corporation. Harcourt, Brace & Company; 1996.
32.
Lustman PJ, et al. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med. 1997;59(1):24–31.PubMed
33.
Diabetes Control and Complications Trial Research Team. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care. 1988;11(9):725–32.CrossRef
34.
Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care. 1994;17(4):267–74.PubMedCrossRef
35.
Ware J, Snow K, Kosinski M, Gandek B. The MOS SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center; 1993.
36.
Glasgow RE, Stryker LA, Toobert DJ, Eakin E. A social-ecological approach to assessing support for disease self-management: The Chronic Illness Resources Survey. J Behav Med. 2000;23(6):559–83.PubMedCrossRef
37.
Diabetes Prevention Program. Diabetes prevention program lifestyle balance core manual. Pittsburgh: University of Pittsburgh; 1996.
38.
Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C. Physical activity/exercise and type 2 diabetes. Diabetes Care. 2004;27:2518–39.PubMedCrossRef
39.
Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A, American College of Sports Medicine; American Heart Association. Physical Activity and Public Health: Updated Recommendation for Adults From the American College of Sports Medicine and the American Heart Association. Circ. 2007;116:1081–93.CrossRef
40.
American College of Sports Medicine. ACSM’s resource manual for guidelines for exercise testing and prescription. 4th ed. Philadelphia: Lippincott, Williams & Wilkins; 2001.
41.
de Groot M, Kushnick M, Shubrook J, Doyle T, Merrill J, McGlynn M, Schwartz F. A model of community-based behavioral intervention for depression in diabetes: Program ACTIVE. Diabetes Spectrum, Winter. 2010;2010:18–25.CrossRef
42.
Hiroe T, Kojima M, Yamamoto I, Nojima S, Kinoshita Y, Hashimoto N, Watanabe N, Maeda T, Furukawa T. Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depression. Psychiatr Res. 2005;135:229–35.CrossRef
Metadata
Title
Can Lifestyle Interventions Do More Than Reduce Diabetes Risk? Treating Depression in Adults With Type 2 Diabetes With Exercise and Cognitive Behavioral Therapy
Authors
Mary de Groot
Todd Doyle
Michael Kushnick
Jay Shubrook
Jennifer Merrill
Erin Rabideau
Frank Schwartz
Publication date
01-04-2012
Publisher
Current Science Inc.
Published in
Current Diabetes Reports / Issue 2/2012
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-012-0261-z

Other articles of this Issue 2/2012

Current Diabetes Reports 2/2012 Go to the issue

Translational Strategies for Diabetes Prevention (D Marrero, Section Editor)

Who Should We Target for Diabetes Prevention and Diabetes Risk Reduction?

Pathogenesis of Type 2 Diabetes and Insulin Resistance (R Watanabe, Section Editor)

A Synergy between Incretin Effect and Intestinal Gluconeogenesis Accounting for the Rapid Metabolic Benefits of Gastric Bypass Surgery

Translational Strategies for Diabetes Prevention (D Marrero, Section Editor)

Necessary Components for Lifestyle Modification Interventions to Reduce Diabetes Risk

Issues in the Nutritional Treatment of Type 2 Diabetes and Obesity (O Hamdy, Section Editor)

Diabetes-Specific Nutrition Algorithm: A Transcultural Program to Optimize Diabetes and Prediabetes Care

Issues in the Nutritional Treatment of Type 2 Diabetes and Obesity (O Hamdy, Section Editor)

Transcultural Diabetes Nutrition Therapy Algorithm: The Asian Indian Application

Translational Strategies for Diabetes Prevention (D Marrero, Section Editor)

Translation of the Diabetes Prevention Program’s Lifestyle Intervention: Role of Community Health Workers
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits